3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
4
INDUSTRY
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Osteosarcoma
1
Neoplasm Metastasis
1
Giant Cell Tumor of Bone
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Radiotherapy
9
Radiosurgery
6
Oxaliplatin
5
Cisplatin
5
Paclitaxel
4
Capecitabine
4
Leucovorin
3
Irinotecan
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
strontium chloride
2
regorafenib
2
pembrolizumab
2
enzalutamide
2
Zoledronic Acid
2
Temozolomide
2
Radiofrequency Ablation
2
Mitomycin
2
Methods
2
Ifosfamide
2
Gemcitabine
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Bleomycin
2
Bevacizumab
2
Analgesia
2
Albumin-Bound Paclitaxel
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Neoplasm Metastasis
×
Denosumab
×
Clear all
NCT03869762
2026-04-13
DICE
Cancer Trials Ireland
Phase 2
Terminated
7 enrolled